Posts Tagged ‘electronic cigarette store in Ogden’

E-cigarettes ‘save lives’, top public health experts tell Government

Tuesday, March 26th, 2013

The Vapor Vault News: Here is a great article that I came across in The Times Health News.

More smokers will die if Governments restrict e-cigarettes, public health experts warn in a letter to The Times. The Government is considering whether e-cigarettes should be classed as medicines and subject to tighter controls, while the EU is considering a total ban.

Professor Gerry Stimson of the school of public health at Imperial College London argues with three co-authors that this would be counterproductive, saying: “It would be an appalling paradox if regulators, in the name of safety, ended up smothering the e-cigarette market with red tape, and so tipped the competitive balance back in favor cigarettes.”

E-cigarettes contain only nicotine, allowing smokers to get their addictive fix without the tobacco that causes so much harm.

“Nicotine itself has minimal health impacts, so e-cigarettes can dramatically reduce the harm to smokers who cannot or will not give up their cigarettes,” say Professor Stimson along with signatories who include Clive Bates, former director of Action on Smoking and Health.

The Medicines and Healthcare Products Regulatory Agency is currently considering how e-cigarettes should be regulated and a a smokesman said: “We are currently working towards making a decision about how to regulate e-cigarettes and we will announce this soon.

“Our view is that products designed to help you beat the addiction to nicotine can fall within the definition of a medicinal product. We would regard any e-cigarette presented as an aid to quitting smoking as being a medicinal product. In the UK, it is illegal to sell e-cigarettes as a ‘quit smoking’ aid unless they are licensed as a medicine by the MHRA.”

New Study of Electronic Cigarette Vapor Confirms that E-Cigs are Much Safer than Regular Cigarettes

Thursday, March 14th, 2013

MONDAY, MARCH 11, 2013

New Study of Electronic Cigarette Vapor Confirms that E-Cigs are Much Safer than Regular Cigarettes

A new study of the chemical constituents of the vapor produced by 12 brands of electronic cigarettes reports that these products greatly reduce exposure to the harmful chemicals in tobacco cigarettes and that e-cigarettes therefore show promise as a harm reduction strategy for tobacco control.(See: Goniewicz ML, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tobacco Control. Published online ahead of print on March 6, 2013. doi: 10.1136/tobaccocontrol-2012-050859.)

In the study, levels of selected carbonyl compounds, volatile organic compounds, tobacco-specific nitrosamines, and metals were analyzed in the vapor of 12 brands of electronic cigarettes and compared to levels of the same compounds in a medicinal nicotine inhaler and in regular tobacco cigarettes.

The results of the study were as follows: “levels of selected toxic compounds found in the smoke from a conventional cigarette were 9-450-fold higher than levels in the vapour of an e-cigarette. … Smoking an e-cigarette (also referred to as ‘vaping’) can result in exposure to carcinogenic formaldehyde comparable with that received from cigarette smoking. Formaldehyde was also found in the vapour of medicinal inhalators, at levels that overlapped with those found in e-cigarette vapour. Exposure to acrolein, an oxidant and respiratory irritant thought to be a major contributor to cardiovascular disease from smoking, is 15 times lower on average in e-cigarette vapour compared with cigarette smoke. The amounts of toxic metals and aldehydes in e-cigarettes are trace amounts and are comparable with amounts contained in an examined therapeutic product.”

The abstract concludes as follows: “Our findings are consistent with the idea that substituting tobacco cigarettes with e-cigarettes may substantially reduce exposure to selected tobacco-specific toxicants. E-cigarettes as a harm reduction strategy among smokers unwilling to quit, warrants further study.”

With regard to the safety of electronic cigarettes compared to real ones, the study concludes: “The results of this study support the proposition that the vapour from e-cigarettes is less injurious than the smoke from cigarettes. Thus one would expect that if a person switched from conventional cigarettes to e-cigarettes the exposure to toxic chemicals and related adverse health effects would be reduced.”

The Rest of the Story

In my opinion, this study provides strong confirmation that electronic cigarettes are much safer than regular cigarettes. At this point, the totality of the scientific evidence is sufficient to conclude that switching from tobacco cigarettes to electronic cigarettes will substantially reduce the health risks associated with smoking. The FDA should allow electronic cigarette companies to make this claim, since it is sufficiently substantiated by scientific studies of the components of electronic cigarette vapor.

It is also important to emphasize that while few electronic cigarette companies are claiming that vaping reduces the hazards associated with smoking, they would not be making a fraudulent, misleading, or unsubstantiated claim if they did make such a statement in their marketing.

Likewise, any anti-smoking advocate or group that continues to claim that there is not evidence that using e-cigarettes is substantially safer than smoking is either unaware of or ignoring the evidence, and possibly making a fraudulent statement themselves.

Note also that this is an independent study which was not funded by any electronic cigarette company. The two funding sources were the Ministry of Science and Higher Education of Poland and the National Institutes of Health.This adds objectivity and credibility to the work.

Although this study demonstrates that e-cigarettes are safer than  tobacco cigarettes, it also refutes the idea that e-cigarettes aresafe in an absolute sense. It appears that the main risk associated with vaping is the potential inhalation of formaldehyde. Formaldehyde may result from the heating of propylene glycol or the oxidation or hydrolysis of glycerin. Of interest, the levels of formaldehyde among the 12 brands of electronic cigarettes ranged from just 3.2 micrograms per 150 puffs (about the same as a nicotine inhaler) to 56.1 micrograms per 150 puffs. This presents an opportunity to examine the reasons for these significant differences and hopefully, to find ways to produce e-cigarette liquid that does not produce high levels of formaldehyde. This should be a research priority for the FDA

The other health concern related to e-cigarette use is the risks associated with long-term inhalation of propylene glycol. If an excipient can be found which allows vaporization of nicotine but avoids propylene glycol and limits the formation of carbonyl compounds such as formaldehyde, it will be a huge advance and may lead to the development of an electronic cigarette product that is not merely safer than smoking, but is essentially safe as well (comparable to a medicinal nicotine product). The development of such a product should also be a priority for the FDA’s Center for Tobacco Products.

Doctors get behind Electronic Cigarettes – The Vapor Vault

Monday, March 11th, 2013

Doctors get behind Electronic Cigarettes – The Vapor Vault

aaphp l121ogoThe American Association of Public Health Physicians is an organization of doctors and scientists that specialize in PUBLIC HEALTH POLICY. It is this organization that advises the American Medical Association on these questions. There IS NO HIGHER MEDICAL AUTHORITY IN THE UNITED STATES WITH REGARD TO PUBLIC HEALTH POLICY. They’ve done real research into tobacco harm, and made the below statement with regard to electronic cigarettes:

Link to the AAPHP
AAPHP Statement re State Regulation of E-cigarettes

The American Association of Public Health Physicians recommends the following State response to proposed legislation to ban or otherwise restrict the sale and use of nicotine vaporizers (commonly referred to as E-cigarettes or electronic cigarettes).

Sale to adults should be permitted.

Sale to minors should be banned.

AAPHP takes no stance on the question of whether E-cigarettes should be banned in no-smoking areas. (see explanation)

An E-cigarette is not a cigarette. It is a metal tube made to look like a cigarette, with a battery, heating element and cartridge containing the substance to be vaporized. The substance is usually a mixture of propylene glycol, glycerin, flavoring, and a specified quantity of nicotine. When the vaper (person using the E-cigarette) inhales, an LED lights up to make the device look more like a cigarette. When he or she exhales, there is a visible cloud of vapor that disappears within a few seconds.

Neither I (Dr. Joel Nitzkin) nor the organization I represent (the American Association of Public Health Physicians) have received or anticipate receipt of any financial support from any E-cigarette, tobacco-related or pharmaceutical enterprise.

AAPHP favors a permissive approach to E-cigarettes because the possibility exists to save the lives of four million of the eight million current adult American smokers who will otherwise die of a tobacco-related illness over the next twenty years.

The only feasible way to achieve this remarkable public health benefit will be to inform smokers of the differences in risk posed by different categories of nicotine-delivery products. Conventional cigarettes account for about 80% of nicotine consumption in the United States, but more than 98% of the illness and death. This harm is not caused by the nicotine, but by toxic products of combustion. A cigarette smoker can reduce his or her risk of future tobacco-related death by 98% or better by switching to a low risk smokeless tobacco product. He or she could cut that risk by 99.9% or better by switching to a nicotine-only delivery product like one of the pharmaceutical products or E-cigarettes.

Experience suggests that E-cigarettes may be more acceptable to smokers than the currently available pharmaceutical alternatives. A smoker can secure almost all the health benefits of quitting if he or she transitions to an E-cigarette.

Quitting, of course, is best. About 3% of smokers succeed in quitting each year. Pharmaceutical smoking cessation products, when used as directed, can increase that to about 7%. Thus, the current pharmaceutical products fail 93% of those who try them, even with the best of health education and counseling. Long term use of an alternative nicotine delivery product can achieve almost all of the benefits of quitting for those unable or unwilling to quit.

E-cigarettes can and should be marketed as a substitute for conventional cigarettes for smokers unable or unwilling to quit. State legislatures and, hopefully the FDA should see them in this light and regulate their marketing to reflect this purpose. Given the current lack of federal regulation, some, but not all, E-cigarette vendors adhere to this guideline. Sales to minors should be prohibited. If someone does not become addicted to nicotine as a minor, it is unlikely that he or she will ever become addicted.

E-cigarettes deliver the same nicotine found in the pharmaceutical products, with no more contamination by toxic substances than the pharmaceutical products already approved by FDA. Propylene glycol and glycerin are used as carriers of the nicotine. These cause the visible vapor. These substances are generally recognized as safe. They are commonly used in theatrical fog machines, asthma inhalers and air fresheners. There is no smoke, and no products of combustion. All this creates a situation in which we can confidently state that the risk to others sharing an indoor environment with one or more vapers (E-cigarette users actively using this product) is almost sure to be much less than 1% the risk posed by environmental tobacco smoke. Pharmaceutical nicotine vaporizers have been in use for years, with no visible vapor, and no apparent concern about use in non-smoking areas. This having been said, we cannot rule out the possibility that some individuals who may be extremely sensitive to indoor air irritants or to miniscule concentrations of nicotine in indoor air might be adversely affected by E-cigarette (or pharmaceutical nicotine vaporizer) vapor.

Another issue is that of modeling. Some worry that sight of E-cigarettes in non-smoking areas will make smoking restrictions harder to enforce, or encourage minors to see smoking as a “normal” and acceptable behavior. It is important to note that, on second glance, E-cigarettes are easy to distinguish from tobacco cigarettes. Those seeing this as a major issue are inclined to ban use of E-cigarettes in non-smoking areas.

We therefore recommend that research be done to address these two issues (possible hazard to a very small number of highly sensitive individuals and modeling). The problem here is that, with end points so difficult to document, such research could cost millions of dollars and take many years to complete. For the reasons noted above, we do not offer a stance in favor of or against banning E-cigarettes in non-smoking areas.

For the data and analyses behind these recommendations, please go to the Tobacco Issues page on our www.aaphp.orgweb site and download the two petitions to FDA (about 20 pages apiece). For yet additional information you can download other documents and the 303 pages of technical reference material relating to the petitions. I would also be happy to respond to any questions or concerns by E-mail.

Joel L. Nitzkin, MD, MPH
Chair, Tobacco Control Task Force
American Association of Public Health Physicians

The Vapor Vault wants you to educate yourself on Electronic Cigarettes!

Saturday, March 9th, 2013

The Vapor Vault wants you to educate yourself on Electronic Cigarettes!

Online PR News – 04-October-2012 –An indoor air quality studyconducted by CHANGE, LLC at the Center for Air Resources Engineering and Science at Clarkson University in Potsdam, NY was published this month in the peer reviewed journal Inhalation Toxicology. The study compared harmful byproducts commonly found in cigarette smoke versus the levels of those same compounds in several popular brands of vaporized e-cigarette liquid.

Because e-cigarettes vaporize liquid rather than burning tobacco, most of the harmful compounds found in smoke were not present in e-cigarette vapor. Those few compounds that were found were at such minuscule levels that toxicology analysis detected no risk (cancer or non-cancer risk) to public health from environmental e-cigarette vapor.

Click here for the full article